Supply Chain/Logistics

UPS joins the Global Health Supply Chain Technical Assistance program to help secure the drug supply chain.

Adents’ Pharma Suite serialization software features track-and-trace capabilities.

World Courier receives pharmaceutical storage and transportation accreditation in the United Kingdom.

CSafe and AES will support controlled-temperature shipping through the Basel, Switzerland airport from their new service center.

The agency requires early notification of potential drug shortages.

The agency gives a limited reprieve to dispensers but requires other trading partners to provide product tracing information.

Pharmacy associates say more education regarding the transactional requirements of DSCSA is needed.

The agency takes action against websites that illegally sell unapproved medications.

Manufacturer supply chain needs are changing in response to widening product temperature ranges.

Agency teams work together to encourage manufacturers to seek approval for previously unapproved drugs.

As an affiliate member, TraceLink brings serialization expertise to the Pharma & Biopharma Outsourcing Association.

A consensus-based standard issued by NSF International incorporates regulatory and industry requirements into a single standard for the manufacturing and distribution of pharmaceutical excipients.

Market changes are driving pharmaceutical companies to consider new ways to mitigate risk in the cold chain.

Enterprise quality management systems can help shift the quality emphasis from corrective to preventive actions.

A new technical report guides bio/pharma companies in establishing a risk-based approach for prevention and management of drug shortages.

Manufacturers face new rules for tracing drugs through the supply chain and compounders face stricter standards.

A guidance document published just before the Jan. 1, 2015 deadline adds a four-month grace period.

Dual sourcing is one of many possible solutions to securing the supply chain.

For cellular therapies to become a viable treatment for large-sized patient groups, steps need to be taken to develop an efficient manufacturing and supply system to minimise the cost of goods.

Regulations, product protection, and cost management are top concerns of supply chain decision makers.

Defining best biopharmaceutical practices is necessary to ensure the safety of the supply chain.

Supplier Audit Program Marks Progress

With globalization, biopharmaceutical companies must establish strategies to minimize vulnerabilities in the raw-materials supply chain.

Challenges in Securing the Biopharma Supply Chain

Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China's Food and Drug Administration's shortened serialization deadline.